Here’s a modest proposal: treat financial derivatives like pharmaceutical products. Just as there is a Food and Drugs Administration to assess the safety of new drugs, so there should be a Financial Products Administration that assesses the safety of proposed new financial instruments. That’d sort out the industry in short order. Imagine the screams from bankers and their lobbyists!